Sample Care Plan Template Page 23
ADVERTISEMENT
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51Levophed
The drug is a
The patient was put
1.88-36.25
Arrhythmias, decreased
Use cautiously with patient
Monitor BP every 5
vasopressor
on Levophed
ml/hr;
urine output,
that have hypertension and
minutes and maintain
and acts
because he became
continuous; IV
hypertension, metabolic
cardiovascular disease.
systolic 80-100 or 30-40
mainly by
hemodynamically
acidosis, fever, and
Alpha-adrenergic blockers
mm Hg below previous
stimulating
unstable and
anxiety (Deglin,
can prevent pressor
systolic. ECG monitored
alpha -
severely bradycardic
Valleran, & Sanoski,
response (Deglin, Valleran,
continuously. Monitor
receptors in
while on the
2013).
& Sanoski, 2013).
urine output and notify
blood vessels.
Propofol for
doctor if less than 30 ml/hr.
The drug
sedation. As long as
(Deglin, Valleran, &
increases BP
the patient is under
Sanoski, 2013).
and cardiac
sedation he will
output
need this medication
(Deglin,
to remain stable.
Valleran, &
The doctors have
Sanoski,
been unsuccessful
2013).
weaning him off
both drugs.
Monitor patient’s
Propofol
General
The drug is used as
10 mg/ml;
Apnea, burning, stinging,
Hypersensitivity to
anesthetics;
an anesthetic to
0.56-41.9
bradycardia,
propofol, soybean oil, egg
respiratory status, heart
The drug is a
maintain the
ml/hr;
hypotension, and pain
lecithin, or glycerol
rate, and BP throughout
patient’s state of
short-acting
continuous; IV
(Deglin, Vallerand, &
(Deglin, Vallerand, &
administration (Deglin,
hypnotic
sedation (Deglin,
Sanoski, 2013).
Sanoski, 2013).
Vallerand, & Sanoski,
whose exact
Vallerand, &
2013).
mechanism of
Sanoski, 2013).
action is
unknown
(Deglin,
Vallerand, &
Sanoski,
2013).
Magnesium
Mineral used
The drug is used
1 g/100 ml;
Drowsiness, decreased
Contraindicated in
Monitor pulse, BP, RR, and
sulfate
as an
PRN for electrolyte
PRN
respiratory rate,
hypermagnesemia,
ECG frequently. Monitor
electrolyte
replacement when
electrolyte
arrhythmias, diarrhea,
hypocalcemia, anuria, and
intake and output ratios
the patient’s lab
replacement
replacement;
muscle weakness, and
heart block (Deglin,
(Deglin, Valleran, &
and is
values indicate it is
IV
hypothermia (Deglin,
Valleran, & Sanoski,
Sanoski, 2013).
essential for
needed.
Valleran, & Sanoski,
2013).
the activity of
2013).
many enzymes
Page 23
F:\group\MEPN\MEPN Level III\NURS610B\2013NURS 610B\610BCarePlan
12/17/2012
ADVERTISEMENT
0 votes
Related Articles
Related forms
Related Categories
Parent category: Medical